Author

A. Griesshammer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:bacteria (other)· 1 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1

Frequent Co-Authors

L. Maier· 2 shared C. Gekeler· 1 shared C. Planker· 1 shared D. Cormontagne· 1 shared D. Rognan· 1 shared E. Bohn· 1 shared G. Andre· 1 shared H. Chang· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

L. Maier

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

An anti-virulence drug targeting the evolvability protein Mfd protects against infections with antimicrobial resistant ESKAPE pathogens

S. L. Tran, L. Lebreuilly, D. Cormontagne, S. Samson, T. B. To, R. Dervyn, A. Griesshammer, J. d. l. C. Zuluaga, L. Maier, T. Naas, S. Mura, J. Nicolas, D. Rognan, G. Andre, n. Ramarao

NM102 targets the Mfd protein to reduce bacterial evolvability and treat infections caused by antibiotic-resistant Gram-negative bacteria.

bioRxiv · Jan 22, 2024Microbiology

Non-antibiotic drugs break colonization resistance against pathogenic Gammaproteobacteria

A. Griesshammer, J. de la Cuesta-Zuluaga, T. Zahir, P. Mueller, C. Gekeler, H. Chang, K. Schmitt, C. Planker, E. Bohn, T. H. Nguyen, K. Casey Huang, L. Maier

The paper tests non-antibiotic drugs' effects on gut microbiome composition and finds some increase Salmonella abundance, potentially increasing infection risk.

bioRxiv · Nov 6, 2023 · PreprintMicrobiology